 PALO ALTO, Calif. and BUFFALO, N.Y., April 13, 2021 GLOBE NEWSWIRE -- BridgeBio Pharma, Inc. NASDAQ: BBIO today announced a collaboration with Roswell Park Comprehensive Cancer Center to advance the development of investigational therapeutics for patients with genetically driven cancers. 